Which drug is used to protect heart muscle in a patient with hyperkalemia?

SGPGI Nursing Officer-2024

Pharmacology

Easy

Appeared in: SGPGI Nursing Officer-2024

Explanation

In hyperkalemia, high potassium levels make cardiac cells more excitable and prone to dangerous arrhythmias.
Calcium gluconate is the first-line emergency treatment for hyperkalemia with ECG changes because it directly antagonizes potassium's effect on the heart.
It works by stabilizing the cardiac cell membrane, raising the action potential threshold, and reducing excitability, which protects the heart from life-threatening rhythms.
This effect is rapid, beginning within minutes, but temporary, lasting about 30-60 minutes.
Crucially, calcium gluconate does not lower the serum potassium level; it only provides immediate cardioprotection while other therapies are initiated to reduce potassium levels.

Option B: Insulin's primary role in hyperkalemia treatment is to shift potassium from the bloodstream into the cells, thereby lowering the serum potassium level. It does not have a direct membrane-stabilizing or cardioprotective effect.
Option C: Sodium bicarbonate can help shift potassium into cells, but its effect is slower and primarily beneficial in patients who also have metabolic acidosis. It does not directly stabilize the cardiac membrane.
Option D: Dextrose has no direct effect on potassium levels or cardiac protection. Its sole purpose is to prevent hypoglycemia when administering insulin to treat hyperkalemia.

Clinical Relevance

Nursing practice connection: Use the key finding related to Pharmacological management of hyperkalemia, specifically focusing on cardioprotection to guide bedside assessment, documentation, and the next nursing action.
In any patient presenting with severe hyperkalemia (K+ greater than 6.5 mEq/L) or any hyperkalemia with ECG changes (peaked T waves, widened QRS), the nurse's priority is to anticipate and facilitate the immediate administration of IV calcium gluconate to prevent cardiac arrest.
A nurse must continuously monitor the patient's ECG and blood pressure during calcium infusion. Bradycardia or hypotension are signs to slow or stop the infusion and notify the provider.
What if? If the hyperkalemic patient is also taking digoxin, IV calcium must be administered with extreme caution (e.g., infused slowly over 20-30 minutes) because hypercalcemia potentiates digoxin toxicity, increasing the risk of arrhythmias.

How to Approach the Question

First, identify the core clinical problem in the question: the need to "protect heart muscle" in a patient with "hyperkalemia."
Recall the pathophysiology of hyperkalemia: high potassium destabilizes cardiac cell membranes, increasing the risk of fatal arrhythmias.
The question asks for the drug that protects the heart, not necessarily the one that lowers potassium. This distinction is critical.
Evaluate the options based on their mechanism of action in this context:
Does it stabilize the cardiac membrane?
Does it shift potassium into cells?

Concept Tested & Keywords

Concept Tested: Pharmacological management of hyperkalemia, specifically focusing on cardioprotection.
Stem keywords: hyperkalemia, protect heart muscle
Lead-in keywords: Which drug

QUrXuqDFcWoIouNr16xjBn

E6 Medicine Harrison 22e Part 1 p. 402-404

E6 Medicine Davidson Principles Practice 24e p. 383-385

E6 Nursing Brunner Adult Health 3SA Vol 1 Part 1 p. 152-154